ResMed's GAAP net income for 9 months of fiscal 2022 was $584.4 million, up 2.1 times from $279.4 million in the prior year. Revenues increased 14.8% to $2.663 billion from $2.32 billion a year earlier.
ResMed's GAAP net income for 9 months of fiscal 2022 was $584.4 million, up 2.1 times from $279.4 million in the prior year. Revenues increased 14.8% to $2.663 billion from $2.32 billion a year earlier. 
investor.resmed.com
English (US) 